Log In
BCIQ
Print this Print this
 

Hanferon SC

  Manage Alerts
Collapse Summary General Information
Company HanAll Biopharma Co. Ltd.
DescriptionInjectable form of an amino acid mutated analogue of interferon-alpha 2b
Molecular Target Interferon alpha 2 (IFNA2)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C virus (HCV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today